DaVita Inc. (NYSE:DVA) Position Raised by Smartleaf Asset Management LLC

Smartleaf Asset Management LLC increased its position in shares of DaVita Inc. (NYSE:DVA) by 16.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 712 shares of the company’s stock after purchasing an additional 101 shares during the period. Smartleaf Asset Management LLC’s holdings in DaVita were worth $107,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in DVA. Wealth Enhancement Advisory Services LLC raised its holdings in DaVita by 8.4% during the third quarter. Wealth Enhancement Advisory Services LLC now owns 3,482 shares of the company’s stock worth $571,000 after purchasing an additional 269 shares in the last quarter. Janney Montgomery Scott LLC raised its holdings in DaVita by 16.4% during the third quarter. Janney Montgomery Scott LLC now owns 24,591 shares of the company’s stock worth $4,031,000 after purchasing an additional 3,468 shares in the last quarter. Asset Management One Co. Ltd. raised its holdings in DaVita by 4.7% during the third quarter. Asset Management One Co. Ltd. now owns 19,629 shares of the company’s stock worth $3,218,000 after purchasing an additional 886 shares in the last quarter. QRG Capital Management Inc. raised its holdings in DaVita by 5.0% during the third quarter. QRG Capital Management Inc. now owns 4,577 shares of the company’s stock worth $750,000 after purchasing an additional 216 shares in the last quarter. Finally, Financial Strategies Group Inc. raised its holdings in DaVita by 19.2% during the third quarter. Financial Strategies Group Inc. now owns 3,135 shares of the company’s stock worth $507,000 after purchasing an additional 504 shares in the last quarter. Institutional investors own 90.12% of the company’s stock.

DaVita Trading Up 4.5 %

NYSE DVA opened at $146.73 on Friday. DaVita Inc. has a twelve month low of $125.64 and a twelve month high of $179.60. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.21 and a current ratio of 1.26. The stock has a market cap of $11.74 billion, a price-to-earnings ratio of 13.66, a PEG ratio of 1.07 and a beta of 0.99. The firm’s 50 day moving average price is $159.58 and its two-hundred day moving average price is $157.87.

DaVita (NYSE:DVA) last posted its quarterly earnings data on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, topping the consensus estimate of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. Equities analysts anticipate that DaVita Inc. will post 10.76 EPS for the current year.

Analyst Ratings Changes

Several research firms have issued reports on DVA. Barclays upped their price target on DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a report on Tuesday, February 18th. Sanford C. Bernstein set a $184.00 price target on DaVita in a report on Friday, February 21st. Finally, Cowen reaffirmed a “hold” rating on shares of DaVita in a report on Tuesday, February 18th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $166.33.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.